Changes of natriuresis and prediction of cardiovascular events in patients with type 2 diabetes and decompensated heart failure over therapy with sodium-glucose cotransporter 2 inhibitors and standard diuretic therapy
Aim. To evaluate the influence and changes of clinical and water-electrolyte parameters on the risk of cardiovascular events in the early period after decompensated heart failure (HF) in patients with type 2 diabetes (T2D), taking into account the influence of standard diuretic therapy and diuretic...
Saved in:
Main Authors: | O. A. Abdullaev, A. G. Arutyunov, D. P. Vereshchak, E. V. Tavlueva, V. A. Konik, N. A. Bylova, D. V. Puzenko, N. P. Kulagina, I. R. Nurieva, T. V. Zanina, G. P. Arutyunov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2024-03-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/5602 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of combining a thiazide diuretic with a loop diuretic in decompensated heart failure: A systematic review and meta-analysis
by: Rodrigo Bessa, et al.
Published: (2025-08-01) -
Current Clinical and Pharmacological Approaches to the Prescription of Loop Diuretics in Patients with Chronic Heart Failure
by: N. M. Gafurova, et al.
Published: (2020-09-01) -
Early diuretic response and outcome prediction in ambulatory worsening heart failure: Natriuresis versus diuresis
by: M. Cobo Marcos, et al.
Published: (2025-08-01) -
Natriuresis as a Way to Assess the Effectiveness of Diuretic Therapy for Acute Decompensated Heart Failure: Data from a Pilot Study
by: K. V. Charaya, et al.
Published: (2023-01-01) -
Efficacy and safety of acetazolamide in patients with NYHA class II-IV decompensated heart failure: protocol of an open-label prospective randomized multicenter study (ORION-A)
by: O. A. Rubanenko, et al.
Published: (2023-09-01)